Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
42
IQV Quote, Financials, Valuation and Earnings
Last price:
$163.29
Seasonality move
:
1.26%
Day range:
$156.16 - $159.80
52-week range:
$134.65 - $252.88
Dividend yield:
0%
P/E ratio:
21.61x
P/S ratio:
1.86x
P/B ratio:
4.59x
Volume:
1.5M
Avg. volume:
2.1M
1-year change:
-31.91%
Market cap:
$27.4B
Revenue:
$15.4B
EPS (TTM):
$7.34
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IQV
IQVIA Holdings
|
$4B | $2.77 | 3.87% | 40.76% | $190.67 |
|
AIRS
AirSculpt Technologies
|
$45.6M | $0.02 | -10.61% | -100% | $4.50 |
|
CVS
CVS Health
|
$94.7B | $1.47 | 3.85% | 3.31% | $79.61 |
|
FPCG
First Physicians Capital Group
|
-- | -- | -- | -- | -- |
|
UNVC
UNIVEC
|
-- | -- | -- | -- | -- |
|
WORX
SCWorx
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IQV
IQVIA Holdings
|
$158.64 | $190.67 | $27.4B | 21.61x | $0.00 | 0% | 1.86x |
|
AIRS
AirSculpt Technologies
|
$5.40 | $4.50 | $337M | 300.71x | $0.00 | 0% | 1.82x |
|
CVS
CVS Health
|
$63.80 | $79.61 | $80.7B | 15.23x | $0.67 | 4.17% | 0.21x |
|
FPCG
First Physicians Capital Group
|
$1,025.00 | -- | $10M | -- | $0.00 | 0% | 1.40x |
|
UNVC
UNIVEC
|
$0.0025 | -- | $453K | -- | $0.00 | 0% | -- |
|
WORX
SCWorx
|
$0.42 | -- | $1.5M | -- | $0.00 | 0% | 0.24x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IQV
IQVIA Holdings
|
70.57% | 0.773 | 46.67% | 0.72x |
|
AIRS
AirSculpt Technologies
|
48.73% | 7.491 | 53.67% | 0.33x |
|
CVS
CVS Health
|
45.69% | 0.923 | 75.52% | 0.59x |
|
FPCG
First Physicians Capital Group
|
-- | 0.000 | -- | -- |
|
UNVC
UNIVEC
|
-- | 1.393 | -- | -- |
|
WORX
SCWorx
|
1.26% | 5.787 | 4.97% | 0.80x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IQV
IQVIA Holdings
|
$1.3B | $525M | 6.62% | 20.79% | 12.75% | $426M |
|
AIRS
AirSculpt Technologies
|
$23.4M | -$1.6M | -11.15% | -21.01% | -4.04% | -$1M |
|
CVS
CVS Health
|
$14.4B | $3.4B | 3.75% | 7% | 3.6% | $3.8B |
|
FPCG
First Physicians Capital Group
|
-- | -- | -- | -- | -- | -- |
|
UNVC
UNIVEC
|
-- | -- | -- | -- | -- | -- |
|
WORX
SCWorx
|
$136.9K | -$334K | -31.86% | -32.77% | -46.37% | -$404.6K |
IQVIA Holdings vs. Competitors
-
Which has Higher Returns IQV or AIRS?
AirSculpt Technologies has a net margin of 6.5% compared to IQVIA Holdings's net margin of -7.23%. IQVIA Holdings's return on equity of 20.79% beat AirSculpt Technologies's return on equity of -21.01%.
Company Gross Margin Earnings Per Share Invested Capital IQVIQVIA Holdings33.9% $1.40 $20.3B AIRSAirSculpt Technologies59.49% -$0.05 $150.8M -
What do Analysts Say About IQV or AIRS?
IQVIA Holdings has a consensus price target of $190.67, signalling upside risk potential of 20.19%. On the other hand AirSculpt Technologies has an analysts' consensus of $4.50 which suggests that it could fall by -16.67%. Given that IQVIA Holdings has higher upside potential than AirSculpt Technologies, analysts believe IQVIA Holdings is more attractive than AirSculpt Technologies.
Company Buy Ratings Hold Ratings Sell Ratings IQVIQVIA Holdings15 7 0 AIRSAirSculpt Technologies0 3 0 -
Is IQV or AIRS More Risky?
IQVIA Holdings has a beta of 1.304, which suggesting that the stock is 30.422% more volatile than S&P 500. In comparison AirSculpt Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock IQV or AIRS?
IQVIA Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AirSculpt Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IQVIA Holdings pays -- of its earnings as a dividend. AirSculpt Technologies pays out -3.05% of its earnings as a dividend.
-
Which has Better Financial Ratios IQV or AIRS?
IQVIA Holdings quarterly revenues are $3.8B, which are larger than AirSculpt Technologies quarterly revenues of $39.4M. IQVIA Holdings's net income of $249M is higher than AirSculpt Technologies's net income of -$2.8M. Notably, IQVIA Holdings's price-to-earnings ratio is 21.61x while AirSculpt Technologies's PE ratio is 300.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings is 1.86x versus 1.82x for AirSculpt Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQVIQVIA Holdings1.86x 21.61x $3.8B $249M AIRSAirSculpt Technologies1.82x 300.71x $39.4M -$2.8M
-
Which has Higher Returns IQV or CVS?
CVS Health has a net margin of 6.5% compared to IQVIA Holdings's net margin of 1.88%. IQVIA Holdings's return on equity of 20.79% beat CVS Health's return on equity of 7%.
Company Gross Margin Earnings Per Share Invested Capital IQVIQVIA Holdings33.9% $1.40 $20.3B CVSCVS Health15.22% $1.41 $141.8B -
What do Analysts Say About IQV or CVS?
IQVIA Holdings has a consensus price target of $190.67, signalling upside risk potential of 20.19%. On the other hand CVS Health has an analysts' consensus of $79.61 which suggests that it could grow by 24.78%. Given that CVS Health has higher upside potential than IQVIA Holdings, analysts believe CVS Health is more attractive than IQVIA Holdings.
Company Buy Ratings Hold Ratings Sell Ratings IQVIQVIA Holdings15 7 0 CVSCVS Health13 7 0 -
Is IQV or CVS More Risky?
IQVIA Holdings has a beta of 1.304, which suggesting that the stock is 30.422% more volatile than S&P 500. In comparison CVS Health has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.598%.
-
Which is a Better Dividend Stock IQV or CVS?
IQVIA Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health offers a yield of 4.17% to investors and pays a quarterly dividend of $0.67 per share. IQVIA Holdings pays -- of its earnings as a dividend. CVS Health pays out 73.1% of its earnings as a dividend. CVS Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios IQV or CVS?
IQVIA Holdings quarterly revenues are $3.8B, which are smaller than CVS Health quarterly revenues of $94.6B. IQVIA Holdings's net income of $249M is lower than CVS Health's net income of $1.8B. Notably, IQVIA Holdings's price-to-earnings ratio is 21.61x while CVS Health's PE ratio is 15.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings is 1.86x versus 0.21x for CVS Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQVIQVIA Holdings1.86x 21.61x $3.8B $249M CVSCVS Health0.21x 15.23x $94.6B $1.8B
-
Which has Higher Returns IQV or FPCG?
First Physicians Capital Group has a net margin of 6.5% compared to IQVIA Holdings's net margin of --. IQVIA Holdings's return on equity of 20.79% beat First Physicians Capital Group's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IQVIQVIA Holdings33.9% $1.40 $20.3B FPCGFirst Physicians Capital Group-- -- -- -
What do Analysts Say About IQV or FPCG?
IQVIA Holdings has a consensus price target of $190.67, signalling upside risk potential of 20.19%. On the other hand First Physicians Capital Group has an analysts' consensus of -- which suggests that it could fall by --. Given that IQVIA Holdings has higher upside potential than First Physicians Capital Group, analysts believe IQVIA Holdings is more attractive than First Physicians Capital Group.
Company Buy Ratings Hold Ratings Sell Ratings IQVIQVIA Holdings15 7 0 FPCGFirst Physicians Capital Group0 0 0 -
Is IQV or FPCG More Risky?
IQVIA Holdings has a beta of 1.304, which suggesting that the stock is 30.422% more volatile than S&P 500. In comparison First Physicians Capital Group has a beta of -12.552, suggesting its less volatile than the S&P 500 by 1355.204%.
-
Which is a Better Dividend Stock IQV or FPCG?
IQVIA Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. First Physicians Capital Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IQVIA Holdings pays -- of its earnings as a dividend. First Physicians Capital Group pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IQV or FPCG?
IQVIA Holdings quarterly revenues are $3.8B, which are larger than First Physicians Capital Group quarterly revenues of --. IQVIA Holdings's net income of $249M is higher than First Physicians Capital Group's net income of --. Notably, IQVIA Holdings's price-to-earnings ratio is 21.61x while First Physicians Capital Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings is 1.86x versus 1.40x for First Physicians Capital Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQVIQVIA Holdings1.86x 21.61x $3.8B $249M FPCGFirst Physicians Capital Group1.40x -- -- --
-
Which has Higher Returns IQV or UNVC?
UNIVEC has a net margin of 6.5% compared to IQVIA Holdings's net margin of --. IQVIA Holdings's return on equity of 20.79% beat UNIVEC's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IQVIQVIA Holdings33.9% $1.40 $20.3B UNVCUNIVEC-- -- -- -
What do Analysts Say About IQV or UNVC?
IQVIA Holdings has a consensus price target of $190.67, signalling upside risk potential of 20.19%. On the other hand UNIVEC has an analysts' consensus of -- which suggests that it could fall by --. Given that IQVIA Holdings has higher upside potential than UNIVEC, analysts believe IQVIA Holdings is more attractive than UNIVEC.
Company Buy Ratings Hold Ratings Sell Ratings IQVIQVIA Holdings15 7 0 UNVCUNIVEC0 0 0 -
Is IQV or UNVC More Risky?
IQVIA Holdings has a beta of 1.304, which suggesting that the stock is 30.422% more volatile than S&P 500. In comparison UNIVEC has a beta of -0.101, suggesting its less volatile than the S&P 500 by 110.112%.
-
Which is a Better Dividend Stock IQV or UNVC?
IQVIA Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UNIVEC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IQVIA Holdings pays -- of its earnings as a dividend. UNIVEC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IQV or UNVC?
IQVIA Holdings quarterly revenues are $3.8B, which are larger than UNIVEC quarterly revenues of --. IQVIA Holdings's net income of $249M is higher than UNIVEC's net income of --. Notably, IQVIA Holdings's price-to-earnings ratio is 21.61x while UNIVEC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings is 1.86x versus -- for UNIVEC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQVIQVIA Holdings1.86x 21.61x $3.8B $249M UNVCUNIVEC-- -- -- --
-
Which has Higher Returns IQV or WORX?
SCWorx has a net margin of 6.5% compared to IQVIA Holdings's net margin of -66.13%. IQVIA Holdings's return on equity of 20.79% beat SCWorx's return on equity of -32.77%.
Company Gross Margin Earnings Per Share Invested Capital IQVIQVIA Holdings33.9% $1.40 $20.3B WORXSCWorx19% -$0.25 $5.7M -
What do Analysts Say About IQV or WORX?
IQVIA Holdings has a consensus price target of $190.67, signalling upside risk potential of 20.19%. On the other hand SCWorx has an analysts' consensus of -- which suggests that it could fall by --. Given that IQVIA Holdings has higher upside potential than SCWorx, analysts believe IQVIA Holdings is more attractive than SCWorx.
Company Buy Ratings Hold Ratings Sell Ratings IQVIQVIA Holdings15 7 0 WORXSCWorx0 0 0 -
Is IQV or WORX More Risky?
IQVIA Holdings has a beta of 1.304, which suggesting that the stock is 30.422% more volatile than S&P 500. In comparison SCWorx has a beta of 2.242, suggesting its more volatile than the S&P 500 by 124.167%.
-
Which is a Better Dividend Stock IQV or WORX?
IQVIA Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SCWorx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IQVIA Holdings pays -- of its earnings as a dividend. SCWorx pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IQV or WORX?
IQVIA Holdings quarterly revenues are $3.8B, which are larger than SCWorx quarterly revenues of $720.3K. IQVIA Holdings's net income of $249M is higher than SCWorx's net income of -$476.3K. Notably, IQVIA Holdings's price-to-earnings ratio is 21.61x while SCWorx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings is 1.86x versus 0.24x for SCWorx. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQVIQVIA Holdings1.86x 21.61x $3.8B $249M WORXSCWorx0.24x -- $720.3K -$476.3K
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
